Antacids Market By Drug Class (Proton Pump Inhibitors, H2 Antagonists, Acid Neutralizers), By Formulation (Tablets, Liquid, Powder & Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & By Region - Global Market Insights 2023 to 2033
Analysis of Antacids Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Antacids Market Outlook (2023 to 2033)
In 2023, the global antacids market is valued at US$ 14 billion and is expected to reach a market size of US$ 22 billion by 2033. The market is forecasted to increase at a CAGR of 4.6% from 2023 to 2033, according to Fact.MR.
- Sales of antacids through online pharmacies are expected to increase faster at a CAGR of 5% over the forecast period due to the rising popularity of the online shopping culture.
- High penetration of smartphones and improvements in telecom services are also driving antacid sales through online pharmacies.
Antacids are over-the-counter (OTC) drugs that reduce indigestion and heartburn by neutralizing the stomach's acid. They are widely offered in easy-to-chew tablet, powder, and liquid forms.
Antacids are extensively used to treat a painful stomach and the discomfort associated with dyspepsia, stomach ulcers, inflammation, acid reflux, and an upset stomach. They help to shield the stomach lining from the esophagus, the duodenum, and the harsh acids produced during digestion. These are self-prescribed drugs that work by reducing stomach acid and inhibiting pepsin.
Global demand for antacids rises as a result of several factors, including bad eating habits, sedentary lifestyles, and regular use of medications to manage high blood pressure. Market players are investing heavily in research and development initiatives to differentiate their products by developing effective antacids.
Manufacturers in the antacids market are approaching drug formulation techniques through consumer-centric means, in the form of chewable and flavored tablets. Lenient legislation regarding the over-the-counter (OTC) availability of antacids is complementing the penetration of antacids through retail pharmacies, convenience stores, and hospital pharmacies.
One of the main reasons driving market expansion is the rising incidence of gastroesophageal reflux disease (GERD). Antacids are extensively used since they are affordable and help to reduce the discomfort, irritation, swelling, and inflammation caused by heartburn.
An increase in product advancements, such as the creation of powerful and safe raft-forming antacids that offer improved efficacy and a longer duration of action, is boosting market expansion. The market is expected to develop as a result of the increasing use of chewable tablets in a variety of flavors that are convenient to store, deliver the right dosage, and enhance patient adherence.
Easy product accessibility through e-Commerce platforms, an expanding geriatric population that is vulnerable to acidic issues, and the rising prevalence of heartburn among the overall population are all contributing to market expansion. The usage of antacids is increasing because many individuals rely on ready-to-eat foods due to a hectic lifestyle.
Antacids Market Size (2023)
US$ 14 Billion
Projected Market Value (2033)
US$ 22 Billion
Global Market Growth Rate (2023 to 2033)
Market Share of Tablets (2023)
Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which are the Key Aspects Driving the Sales of Antacids?
“Rising Incidence of GERD in Geriatric Population”
Rising elderly population with gastroesophageal reflux disease (GERD) is one of the factors driving market expansion. As the elderly are particularly susceptible to peptic ulcers and gastroesophageal reflux disease, the growing geriatric population is one of the most promising development factors for the antacids industry. It is predicted that the geriatric population will suffer a rise in GERD, which will raise the demand for antacids.
Symptomatic conditions, including Barrett's esophagus and esophageal cancer, are usually present in the geriatric population. An array of therapies are employed to treat these problems, and antacid use has greatly increased in these circumstances, which is anticipated to fuel market expansion over the coming years.
“Growing Prevalence of Gastrointestinal Issues”
The global market for antacids is being driven by the rising prevalence of gastrointestinal issues. The adoption of sedentary lifestyles also contributes to several acidity-related issues. Because of this, customers are turning to antacids and other digestion aids. As a result, antacid medications are sold over the counter and come in a variety of flavors at a reasonable price.
Increased emphasis on the release of high-quality medications and rising demand for early diagnosis among consumers are anticipated to boost market growth throughout the forecast period. Rising awareness of the early signs of gastrointestinal illnesses is also positive for market expansion.
“Increasing Popularity of Mouth-melting Antacids”
A new development in the antacid industry is the use of mouth-melting antacids. Until now, antacids could only be found in tablet, liquid, or powder form; however, researchers have now developed mouth-melting antacids, which are composed of tiny mouth-melting granules that quickly dissolve in the mouth. These effervescent granules that are found in antacids do their function.
- Sunpharma's 'Pepmelt', which combines the benefits of the herbal components it contains with modern mouth-melting technology, is an example of a mouth-melting quick relief antacid.
Nowadays, natural plant extracts to reduce stomach acidity are used to create antacid medication compositions. For the treatment of issues associated with acidity, OTC herbal and traditional medicines are used.
What are the Challenges Faced by Antacid Providers?
“Availability of Antacid Substitutes and Lack of Awareness of Acidity Symptoms”
Pricing trends indicate that high costs of raw materials are impeding market expansion. Key raw materials such as calcium carbonate and magnesium hydroxide have seen a price increase recently.
The market for antacids is also being challenged by a rise in regulations that are being enforced by governments all over the world. These rules, which are intended to ensure consumer safety, will probably continue to present difficulties for businesses.
The availability of antacid substitutes and a lack of awareness of acidity symptoms are predicted to hamper market expansion. Market growth is anticipated to be constrained by several factors, including side effects such as constipation, a laxative effect, and allergic responses.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Can Start-ups Gain Profits in This Competitive Space?
“New Entrants Introducing More Effective and Long-lasting Antacids”
New companies are offering more effective and long-lasting antacids. Emerging market players are introducing new flavors to meet consumers' constantly shifting preferences.
- A start-up based in Austin, Wonderbelly, offers effective, more environment-friendly, and cleaner digestive health medication. This antacid is non-GMO and free of talc, colors, and other harmful substances. Wonderbelly promises to utilize healthier ingredients and provides FDA-approved over-the-counter goods that are 100% plastic-free.
Why is Europe Dominating the Global Antacids Market?
“Increasing Government Initiatives for Early Detection & Gastrointestinal Bleeding Treatment”
- Europe is the leading regional antacids market with 50% share at present.
Rising sales of antacids through online pharmacies and the presence of top antacid manufacturers are boosting market value in the region. Increasing government initiatives for early detection and gastrointestinal bleeding treatment are supporting market expansion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Will the United States Be an Investment-worthy Market for Manufacturers of Antacids?
“Presence of Advanced Pharmaceutical Laboratories”
The market in the United States is driven by the presence of advanced pharmaceutical laboratories and the growing popularity of self-medication. The market in the United States is anticipated to grow as a result of the rising incidence of GERD due to lifestyle changes. Antacid medications are projected to be in demand in the United States due to the rising frequency of gastrointestinal illnesses.
What is Driving Antacid Demand across Germany?
“Favorable Reimbursement Policies”
The market in Germany is expanding because of the rising geriatric population, excessive consumption of unhealthy foods, and favorable reimbursement policies. An increase in efforts by pharmaceutical companies to raise awareness about acidity symptoms and the high demand for over-the-counter digestive medicines are factors driving market growth.
Why are Sales of Antacids High in Japan?
“Presence of Well-developed Healthcare Infrastructure”
Market growth in Japan is attributed to the presence of a well-developed healthcare infrastructure, rising disposable income, and an expanding pharmaceutical industry. Growing consumer awareness about antacids, the presence of advanced diagnostic services, and the availability of efficient treatment options are some of the key factors driving market expansion.
Which Formulation is Estimated to Contribute to Substantial Market Revenue Share?
“Tablets Preferred Owing to Ease of Consumption and Storage Convenience”
By formulation, the market is segmented into tablets, liquid, powder, and others.
- Tablets account for 50% share of the global market in 2023.
Convenience is a significant feature leading to an increase in the demand for antacids in the tablet format. Tablets will remain the leading choice of consumers suffering from GERD, owing to their administered dosage, ease of consumption, and storage convenience. The availability of leading drug classes in the tablet format is further adding sheen to the growing popularity of tablets in the market.
Why are Online Pharmacies Widely Preferred for Buying Antacids?
“Convenience of Home Delivery of Therapeutics”
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
Online pharmacies are favored by customers due to their appealing marketing, price savings, easy access to pharmaceuticals, and home delivery options. Online pharmacies are becoming a standard distribution route for antacids. Online sales are on the rise in the worldwide antacids industry, which is dominated by over-the-counter (OTC) medications that don't need a prescription.
The main factor in the growth of e-Commerce retailing has been the efforts made by the retailers to enhance the online buying experience through improved online education and targeted marketing. Sales of antacids are further boosted by the robust viability of e-Commerce platforms. Internet merchants also provide free access to various online deals.
Leading companies are embracing tactics, including strategic alliances, quality control, acquisitions, product standards, supply chain management, and collaborations, to increase their geographic reach and improve their competitive position. Top antacid producers are focusing on new developments and introducing new products while following safety regulations to meet consumer demand.
- In 2020, Horizon Therapeutics PLC's Vimovo delayed-release tablets were introduced by Lupin. The medication is used to lower the risk of stomach ulcers caused by naproxen.
Key Segments Covered in Antacids Industry Research
By Drug Class :
- Proton Pump Inhibitors
- H2 Antagonists
- Acid Neutralizers
By Formulation :
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region :
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- FAQs -
The global antacids market is valued at US$ 14 billion in 2023.
Sales of antacids are set to reach US$ 22 billion by 2033.
Demand for antacids is forecasted to increase at a CAGR of 4.6% through 2033.
Bayer AG, GlaxoSmithKline plc, and Mylan N.V. are the top suppliers of antacids.
At present, Europe holds 50% share of the global market for antacids.